Viibryd Dosage: Starter Kits, Target Doses, and the Food Rule
Clinically reviewed by Daniel Montville, MD
Reviewed October 21, 2026 · Last updated September 28, 2026
Key Takeaways
- Viibryd starts at 10 mg once daily with food for 7 days, then moves to 20 mg, with an optional increase to 40 mg after at least another 7 days.
- The current label treats 20 mg to 40 mg as the target range, a change from the original 2011 label that pointed everyone to 40 mg.
- FDA reviewers concluded that Viibryd needs a gradual start to minimize stomach side effects and must be taken with food to reach adequate blood levels.
- Taken on an empty stomach, total Viibryd exposure can drop by about half, which may make it less effective.
Your first Viibryd prescription may have arrived as a starter kit: one box, three tablet colors, and a schedule that climbs week by week. Or maybe the pharmacist said “take it with food” twice and you’re not sure why it matters so much. Both parts of the instructions have a specific reason behind them, and knowing those reasons makes the first month easier to follow.
Your body doesn’t absorb every medicine the same way. Some pass into the bloodstream about equally whether you’ve eaten or not, while others depend heavily on what’s in your stomach. Vilazodone, the drug in Viibryd, is one that depends on food, and it also tends to unsettle the gut early on. Getting the dose right takes precision about two things: how quickly the dose climbs and whether there’s food with every tablet.
Viibryd builds on a well-studied approach. Like SSRIs, it blocks the reuptake of serotonin, and it also partially activates serotonin 5-HT1A receptors. The Viibryd prescribing information describes four placebo-controlled trials in which it improved depression: three tested 40 mg a day, one tested both 20 mg and 40 mg, and every one built in a titration schedule. The dosing rules are clear, and the evidence behind them is solid.
But a schedule printed on a box doesn’t explain itself, and at Siggy we’d rather you understand why each step exists than follow it blind. The fixed first week, the food requirement, and the choice between 20 mg and 40 mg each trace back to specific findings, including a label change that many dosing guides skip. When you know what each rule protects, you’re much more likely to follow it through the weeks when side effects peak. The schedule reflects how the drug was tested and absorbed, which is a stronger reason than habit.
What This Page Covers
- The Short Answer
- How Viibryd Dosing Works
- What the Starter Kits Contain
- Why the First Week Is Fixed at 10 mg
- 20 mg or 40 mg: What the Trials Show
- Why Viibryd Has to Be Taken With Food
- When Your Dose May Need to Change
- How to Stop Viibryd Safely
The Short Answer
Most adults take Viibryd once a day with food, starting at 10 mg for 7 days and then moving to 20 mg. If more is needed, the dose can go to 40 mg after at least another 7 days. The target range is 20 mg to 40 mg.
Two rules matter more than the numbers. Don’t skip the first week at 10 mg, and don’t take Viibryd on an empty stomach. The first rule is about side effects, and the second is about whether the medication can work at all.
How Viibryd Dosing Works
Viibryd comes as 10 mg, 20 mg, and 40 mg tablets. According to the prescribing information, it reaches steady levels in about 3 days and has a half-life of about 25 hours, so each dose change settles within days rather than weeks.
The dosing steps and adjustments in the current prescribing information fit into a small set of situations:
| Situation | Dose | Timing Note |
|---|---|---|
| Starting treatment | 10 mg with food | Once daily for 7 days |
| Step two | 20 mg with food | Target dose for many people |
| Optional increase | 40 mg with food | At least 7 days after last increase |
| With a strong CYP3A4 inhibitor | No more than 20 mg | Resume usual dose when it stops |
| With a strong CYP3A4 inducer | Up to twice the dose, 80 mg max | After more than 14 days together |
The original 2011 label was simpler and stricter. The 2011 Viibryd label set the recommended dose at 40 mg, reached by 10 mg for 7 days and 20 mg for another 7 days. Today’s label treats 20 mg as a full target dose and makes 40 mg optional.
What the Starter Kits Contain
The current prescribing information lists two 30-tablet patient starter kits, one for each version of the plan:
- A kit ending at 40 mg holds seven 10 mg tablets, seven 20 mg tablets, and sixteen 40 mg tablets.
- A kit ending at 20 mg holds seven 10 mg tablets and twenty-three 20 mg tablets.
The tablet counts line up with the label’s schedule: one week at 10 mg, one week at 20 mg, and the rest of the month at your target dose. The kits are a convenience. If your prescriber wants you to spend longer at a step, you can do that with individual bottles instead.
Why the First Week Is Fixed at 10 mg
Stomach side effects are the main reason. In the label’s pooled trials, diarrhea affected 26% to 29% of people on Viibryd compared with 10% on placebo, and nausea affected 22% to 24% compared with 7%. A 2012 systematic review calculated that about one extra person in every six treated developed each symptom.
FDA reviewers addressed this directly. In a review by FDA scientists explaining the approval, the authors concluded that vilazodone needs to be adjusted up gradually to minimize gastrointestinal symptoms. Every efficacy and safety number in the label was collected on that stepped schedule, which is why prescribers stick to it.
What the trials didn’t do is test whether skipping the step makes side effects worse, so the size of the benefit isn’t known. Most of these effects were mild to moderate: in a one-year safety study of 599 people on 40 mg a day, more than 90% of diarrhea and nausea events fell in that range. Our guide to Viibryd side effects covers them in detail.
20 mg or 40 mg: What the Trials Show
Both doses work. In a 10-week trial of 1,133 adults, vilazodone 20 mg and 40 mg each improved depression scores more than placebo, and so did the comparison drug, citalopram. Vomiting reached the threshold for a common side effect only in the 40 mg group.
The label’s pooled data are reassuring on tolerability, reporting no dose-related side effects between 20 mg and 40 mg. Taken together, 20 mg is a reasonable place to stay if it’s working, and 40 mg is an option if it isn’t. The same benefit-versus-tolerability logic applies to SSRIs, as our guide to how doctors decide on a Lexapro dose explains.
The decision to go higher works best after the 20 mg dose has had time to show what it can do. Talk with your prescriber about how your mood, sleep, and energy are changing rather than moving up on a fixed date.
Why Viibryd Has to Be Taken With Food
This rule is about absorption. The prescribing information reports that vilazodone’s bioavailability, the share of a dose that reaches your bloodstream, is 72% when taken with food. On an empty stomach, total exposure can fall by about 50% and peak levels by about 60%, and the label warns this can leave drug levels too low and reduce effectiveness.
The FDA review reached the same conclusion, stating that vilazodone must be taken with food to ensure adequate blood levels. The label simply says “with food” and doesn’t specify a meal size, so the practical habit is to take it with a regular meal at the same time each day.
Food doesn’t prevent the stomach side effects, though. The label notes that its trials gave Viibryd with food, so the diarrhea and nausea rates above were recorded in people who were already eating with their doses. If you vomit within 7 hours of a dose, absorption drops by about 25%, and the label says no replacement dose is needed.
When Your Dose May Need to Change
Other medications can change how much vilazodone reaches your blood. Strong CYP3A4 inhibitors, such as itraconazole, clarithromycin, or voriconazole, raise levels, and the label caps Viibryd at 20 mg while you take one. Strong inducers, such as carbamazepine, phenytoin, or rifampin, lower levels, and the label allows a gradual increase up to twice the dose, to a maximum of 80 mg, when one is taken for more than 14 days.
If you miss a dose, take it when you remember unless it’s almost time for the next one. Never take two doses at once. Tell every prescriber and pharmacist that you take Viibryd, since its serotonin effects add to other serotonergic drugs and raise the risk of serotonin syndrome.
How to Stop Viibryd Safely
Viibryd shouldn’t be stopped suddenly. The label recommends reducing 40 mg to 20 mg for 4 days, then 10 mg for 3 days, before stopping. People on 20 mg reduce to 10 mg for 7 days first. It lists possible discontinuation symptoms including nausea, dizziness, irritability, anxiety, and electric-shock sensations.
Those label steps are a starting point. The NICE depression guideline advises tapering in proportional steps and making sure withdrawal symptoms have resolved or are tolerable before the next reduction. If a step feels rough, your prescriber can hold the dose longer or slow down.
Like all antidepressants, Viibryd carries a boxed warning about suicidal thoughts and behaviors in people 24 and younger, especially early in treatment and after dose changes. If you have thoughts of harming yourself, call or text 988. If you’re in immediate danger, call 911.
With Viibryd, the first two weeks matter most, because the dose is climbing just as stomach side effects tend to show up.
Viibryd’s dosing rules are short, and each one has a reason. The fixed first week protects your stomach, the food rule protects the dose itself, and the choice between 20 mg and 40 mg rests on how you respond. Knowing that makes it easier to stay the course through the early weeks and to have a specific conversation with your prescriber about what comes next.
Ready to take control of your mental health? Start your anonymous intake with Siggy and get your plan reviewed by a licensed prescriber.
This article is for education only and isn’t a substitute for personal medical advice. Talk with your own clinician before starting, changing, or stopping any medication.
Mental healthcare should stay with you between appointments.
Siggy combines daily check-ins with clinician-supervised care so your treatment plan can respond to what is actually happening.
Start anonymously. A real doctor reviews every clinical decision. HIPAA-compliant.
Frequently Asked Questions
What is the usual Viibryd dosage?
The recommended target is 20 mg to 40 mg once daily with food. Treatment starts at 10 mg once daily with food for 7 days, then increases to 20 mg. Your prescriber may raise it to 40 mg after at least another 7 days, depending on how you respond and how well you tolerate it.
What comes in a Viibryd starter kit?
The FDA label describes two 30-tablet patient starter kits. One contains seven 10 mg tablets, seven 20 mg tablets, and sixteen 40 mg tablets. The other contains seven 10 mg tablets and twenty-three 20 mg tablets, for people whose plan stops at 20 mg.
Is 20 mg of Viibryd enough?
For many people, yes. In a 10-week trial of 1,133 adults, both 20 mg and 40 mg improved depression more than placebo, and the current label lists 20 mg to 40 mg as the target range. Whether you need 40 mg depends on your response, which your prescriber can judge after you've been on 20 mg for a while.
What happens if I take Viibryd without food?
You may absorb much less of it. The label says total exposure can drop by about 50% and peak levels by about 60% on an empty stomach, which can leave drug levels too low and reduce effectiveness. Take it with a meal every day for a consistent dose.
What if I vomit after taking Viibryd?
You don't need to take another dose. The label says absorption drops by about 25% if vomiting happens within 7 hours of a dose, and no replacement dose is needed. If vomiting keeps happening, tell your prescriber.
How do you stop taking Viibryd?
Gradually, with your prescriber. The label recommends reducing 40 mg to 20 mg for 4 days and then 10 mg for 3 days, or 20 mg to 10 mg for 7 days, before stopping. If withdrawal symptoms appear, your prescriber can slow the pace.
Sources
- U.S. National Library of Medicine. Viibryd (vilazodone hydrochloride) Tablets Prescribing Information. Allergan, Inc. DailyMed. Revised October 2023. dailymed.nlm.nih.gov
- U.S. Food and Drug Administration. Viibryd (vilazodone hydrochloride) Tablets Prescribing Information. Original approval label, 2011. accessdata.fda.gov
- Citrome L. Vilazodone for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant. International Journal of Clinical Practice. 2012;66(4):356-368. doi:10.1111/j.1742-1241.2011.02885.x
- Laughren TP, Gobburu J, Temple RJ, et al. Vilazodone: clinical basis for the US Food and Drug Administration’s approval of a new antidepressant. Journal of Clinical Psychiatry. 2011;72(9):1166-1173. doi:10.4088/JCP.11r06984
- Robinson DS, Kajdasz DK, Gallipoli S, et al. A 1-year, open-label study assessing the safety and tolerability of vilazodone in patients with major depressive disorder. Journal of Clinical Psychopharmacology. 2011;31(5):643-646. doi:10.1097/JCP.0b013e31822c6741
- Mathews M, Gommoll C, Chen D, Nunez R, Khan A. Efficacy and safety of vilazodone 20 and 40 mg in major depressive disorder: a randomized, double-blind, placebo-controlled trial. International Clinical Psychopharmacology. 2015;30(2):67-74. doi:10.1097/YIC.0000000000000057
- National Institute for Health and Care Excellence. Depression in adults: treatment and management (NG222). Recommendations. 2022. nice.org.uk